1. Home
  2. JBLU vs RLAY Comparison

JBLU vs RLAY Comparison

Compare JBLU & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JetBlue Airways Corporation

JBLU

JetBlue Airways Corporation

HOLD

Current Price

$5.10

Market Cap

1.5B

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$7.60

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JBLU
RLAY
Founded
1998
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
JBLU
RLAY
Price
$5.10
$7.60
Analyst Decision
Sell
Strong Buy
Analyst Count
11
7
Target Price
$4.69
$16.00
AVG Volume (30 Days)
18.1M
2.0M
Earning Date
01-27-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,095,000,000.00
$8,355,000.00
Revenue This Year
N/A
$19.96
Revenue Next Year
$8.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.34
$1.78
52 Week High
$8.21
$9.04

Technical Indicators

Market Signals
Indicator
JBLU
RLAY
Relative Strength Index (RSI) 52.57 44.44
Support Level $4.66 $7.36
Resistance Level $5.75 $7.91
Average True Range (ATR) 0.27 0.46
MACD 0.02 -0.08
Stochastic Oscillator 38.52 32.42

Price Performance

Historical Comparison
JBLU
RLAY

About JBLU JetBlue Airways Corporation

JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Share on Social Networks: